IRIS Accounts Production v23.4.0.336 04261332 Board of Directors 1.1.23 31.12.23 31.12.23 dental equipment and sundries supplier. false true true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042613322022-12-31042613322023-12-31042613322023-01-012023-12-31042613322021-12-31042613322022-01-012022-12-31042613322022-12-3104261332ns15:EnglandWales2023-01-012023-12-3104261332ns14:PoundSterling2023-01-012023-12-3104261332ns10:Director12023-01-012023-12-3104261332ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3104261332ns10:FRS1022023-01-012023-12-3104261332ns10:Audited2023-01-012023-12-3104261332ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3104261332ns10:FullAccounts2023-01-012023-12-310426133212023-01-012023-12-3104261332ns10:OrdinaryShareClass12023-01-012023-12-3104261332ns10:Director22023-01-012023-12-3104261332ns10:Director32023-01-012023-12-3104261332ns10:Director42023-01-012023-12-3104261332ns10:RegisteredOffice2023-01-012023-12-3104261332ns5:CurrentFinancialInstruments2023-12-3104261332ns5:CurrentFinancialInstruments2022-12-3104261332ns5:Non-currentFinancialInstruments2023-12-3104261332ns5:Non-currentFinancialInstruments2022-12-3104261332ns5:ShareCapital2023-12-3104261332ns5:ShareCapital2022-12-3104261332ns5:RetainedEarningsAccumulatedLosses2023-12-3104261332ns5:RetainedEarningsAccumulatedLosses2022-12-3104261332ns5:ShareCapital2021-12-3104261332ns5:RetainedEarningsAccumulatedLosses2021-12-3104261332ns5:RetainedEarningsAccumulatedLosses2022-01-012022-12-3104261332ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-3104261332ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2023-01-012023-12-3104261332ns5:LeaseholdImprovements2023-01-012023-12-3104261332ns5:PlantMachinery2023-01-012023-12-3104261332ns5:FurnitureFittings2023-01-012023-12-3104261332ns5:ComputerEquipment2023-01-012023-12-3104261332ns5:ReportableOperatingSegment12023-01-012023-12-3104261332ns5:ReportableOperatingSegment12022-01-012022-12-3104261332ns5:ReportableOperatingSegment22023-01-012023-12-3104261332ns5:ReportableOperatingSegment22022-01-012022-12-3104261332ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-01-012023-12-3104261332ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2022-01-012022-12-3104261332ns15:UnitedKingdom2023-01-012023-12-3104261332ns15:UnitedKingdom2022-01-012022-12-3104261332ns15:Europe2023-01-012023-12-3104261332ns15:Europe2022-01-012022-12-3104261332ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-01-012023-12-3104261332ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2022-01-012022-12-3104261332ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-01-012023-12-3104261332ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2022-01-012022-12-3104261332ns5:OwnedAssets2023-01-012023-12-3104261332ns5:OwnedAssets2022-01-012022-12-3104261332ns5:LeasedAssets2023-01-012023-12-3104261332ns5:LeasedAssets2022-01-012022-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2022-01-012022-12-3104261332132023-01-012023-12-3104261332132022-01-012022-12-3104261332ns10:OrdinaryShareClass12022-01-012022-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2022-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3104261332ns5:PatentsTrademarksLicencesConcessionsSimilar2022-12-3104261332ns5:LeaseholdImprovements2022-12-3104261332ns5:PlantMachinery2022-12-3104261332ns5:FurnitureFittings2022-12-3104261332ns5:ComputerEquipment2022-12-3104261332ns5:LeaseholdImprovements2023-12-3104261332ns5:PlantMachinery2023-12-3104261332ns5:FurnitureFittings2023-12-3104261332ns5:ComputerEquipment2023-12-3104261332ns5:LeaseholdImprovements2022-12-3104261332ns5:PlantMachinery2022-12-3104261332ns5:FurnitureFittings2022-12-3104261332ns5:ComputerEquipment2022-12-3104261332ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-01-012023-12-3104261332ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-12-3104261332ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3104261332ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3104261332ns5:FinanceLeasesns5:WithinOneYear2023-12-3104261332ns5:FinanceLeasesns5:WithinOneYear2022-12-3104261332ns5:BetweenOneFiveYearsns5:FinanceLeases2023-12-3104261332ns5:BetweenOneFiveYearsns5:FinanceLeases2022-12-3104261332ns5:FinanceLeases2023-12-3104261332ns5:FinanceLeases2022-12-3104261332ns5:CurrentFinancialInstrumentsns5:FinanceLeasesns5:WithinOneYear2023-12-3104261332ns5:CurrentFinancialInstrumentsns5:FinanceLeasesns5:WithinOneYear2022-12-3104261332ns5:WithinOneYear2023-12-3104261332ns5:WithinOneYear2022-12-3104261332ns5:BetweenOneFiveYears2023-12-3104261332ns5:BetweenOneFiveYears2022-12-3104261332ns5:AllPeriods2023-12-3104261332ns5:AllPeriods2022-12-3104261332ns5:AcceleratedTaxDepreciationDeferredTax2023-12-3104261332ns5:AcceleratedTaxDepreciationDeferredTax2022-12-3104261332ns5:DeferredTaxation2022-12-3104261332ns5:DeferredTaxation2023-01-012023-12-3104261332ns5:DeferredTaxation2023-12-3104261332ns10:OrdinaryShareClass12023-12-3104261332ns5:RetainedEarningsAccumulatedLosses2022-12-31
REGISTERED NUMBER: 04261332 (England and Wales)

















Report of the Directors and

Financial Statements for the Year Ended 31 December 2023

for

Top Dental (Products) Limited

Top Dental (Products) Limited (Registered number: 04261332)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Report of the Directors 2

Report of the Independent Auditors 4

Income Statement 7

Other Comprehensive Income 8

Balance Sheet 9

Statement of Changes in Equity 11

Cash Flow Statement 12

Notes to the Cash Flow Statement 13

Notes to the Financial Statements 14


Top Dental (Products) Limited

Company Information
for the Year Ended 31 December 2023







DIRECTORS: Mr. H C E Karsk
Mrs M U Hallen Tabrizi
Mr S D Rollen
Mrs E R Hansell





REGISTERED OFFICE: 12 Ryefield Way
Silsden
Keighley
West Yorkshire
BD20 0EF





REGISTERED NUMBER: 04261332 (England and Wales)





AUDITORS: Sutton McGrath Hartley Ltd
Statutory Auditors & Chartered Accountants
5 Westbrook Court
Sharrowvale Road
Sheffield
South Yorkshire
S11 8YZ

Top Dental (Products) Limited (Registered number: 04261332)

Report of the Directors
for the Year Ended 31 December 2023

The directors present their report with the financial statements of the company for the year ended 31 December 2023.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2023 to the date of this report.

Mr. H C E Karsk
Mrs M U Hallen Tabrizi
Mr S D Rollen

Other changes in directors holding office are as follows:

Mrs E R Hansell - appointed 30 June 2023

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Sutton McGrath Hartley Ltd, will be proposed for re-appointment at the forthcoming Annual General Meeting.


Top Dental (Products) Limited (Registered number: 04261332)

Report of the Directors
for the Year Ended 31 December 2023

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Mr. H C E Karsk - Director


25 March 2024

Report of the Independent Auditors to the Members of
Top Dental (Products) Limited

Opinion
We have audited the financial statements of Top Dental (Products) Limited (the 'company') for the year ended 31 December 2023 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2023 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Report of the Directors has been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Top Dental (Products) Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit; or
- the directors were not entitled to take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Directors.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page two, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Top Dental (Products) Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our assessment of the susceptibility to material misstatement, whether by fraud or error, is made in a risk based
approach.

In this approach, laws and regulations applicable to the entity, such as the Companies Act 2006, United Kingdom
Generally Accepted Accounting Practice including Financial Reporting Standard 101, the relevant tax compliance
regulations within the UK, employment law, and Health and Safety law is considered, and the policies and controls the entity has in place to comply with these laws are reviewed, by discussion, reviews of correspondence and registrations monitored by external bodies. The engagement team remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Policies and controls relating to the risk of material misstatement as a result of fraud are also considered. These are assessed by obtaining an understanding of the company's operations and control environment. The policies and controls have been reviewed by discussion, review and sample testing of accounting entries, challenging assumptions and judgements, reviewing and evaluating related parties transactions, and wider background searches. Testing of income recognition and cut off, along with testing of inventory valuation is also completed.

We have ensured that the engagement team have appropriate levels of competence and experience to effectively monitor these risks and carry out work relevant to our assessment of each risk, including consideration of the industry the company operates in and its size and complexity.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Jonathon Dickens ACA (Senior Statutory Auditor)
for and on behalf of Sutton McGrath Hartley Ltd
Statutory Auditors & Chartered Accountants
5 Westbrook Court
Sharrowvale Road
Sheffield
South Yorkshire
S11 8YZ

3 April 2024

Top Dental (Products) Limited (Registered number: 04261332)

Income Statement
for the Year Ended 31 December 2023

2023 2022
Notes £ £

TURNOVER 3 5,184,202 4,935,278

Cost of sales 3,357,578 3,148,361
GROSS PROFIT 1,826,624 1,786,917

Administrative expenses 1,523,822 1,560,244
302,802 226,673

Other operating income 2,425 -
OPERATING PROFIT 5 305,227 226,673

Interest receivable and similar income 27,309 6,345
332,536 233,018

Interest payable and similar expenses 6 5,443 -
PROFIT BEFORE TAXATION 327,093 233,018

Tax on profit 7 80,871 55,137
PROFIT FOR THE FINANCIAL YEAR 246,222 177,881

Top Dental (Products) Limited (Registered number: 04261332)

Other Comprehensive Income
for the Year Ended 31 December 2023

2023 2022
Notes £ £

PROFIT FOR THE YEAR 246,222 177,881


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

246,222

177,881

Top Dental (Products) Limited (Registered number: 04261332)

Balance Sheet
31 December 2023

2023 2022
Notes £ £ £ £
FIXED ASSETS
Intangible assets 9 234,170 246,209
Tangible assets 10 362,147 332,417
596,317 578,626

CURRENT ASSETS
Stocks 11 437,610 626,049
Debtors 12 687,961 747,515
Cash at bank and in hand 1,373,175 760,542
2,498,746 2,134,106
CREDITORS
Amounts falling due within one year 13 1,083,705 578,771
NET CURRENT ASSETS 1,415,041 1,555,335
TOTAL ASSETS LESS CURRENT LIABILITIES 2,011,358 2,133,961

CREDITORS
Amounts falling due after more than one
year

14

(52,824

)

-

PROVISIONS FOR LIABILITIES 16 (27,973 ) (26,586 )
NET ASSETS 1,930,561 2,107,375

CAPITAL AND RESERVES
Called up share capital 17 100 100
Retained earnings 18 1,930,461 2,107,275
SHAREHOLDERS' FUNDS 1,930,561 2,107,375

Top Dental (Products) Limited (Registered number: 04261332)

Balance Sheet - continued
31 December 2023



The financial statements were approved by the Board of Directors and authorised for issue on 25 March 2024 and were signed on its behalf by:





Mr. H C E Karsk - Director


Top Dental (Products) Limited (Registered number: 04261332)

Statement of Changes in Equity
for the Year Ended 31 December 2023

Called up
share Retained Total
capital earnings equity
£ £ £
Balance at 1 January 2022 100 1,929,394 1,929,494

Changes in equity
Total comprehensive income - 177,881 177,881
Balance at 31 December 2022 100 2,107,275 2,107,375

Changes in equity
Dividends - (423,036 ) (423,036 )
Total comprehensive income - 246,222 246,222
Balance at 31 December 2023 100 1,930,461 1,930,561

Top Dental (Products) Limited (Registered number: 04261332)

Cash Flow Statement
for the Year Ended 31 December 2023

2023 2022
Notes £ £
Cash flows from operating activities
Cash generated from operations 1 793,444 201,082
Finance costs paid (5,443 ) -
Tax paid (105,485 ) 105,352
Net cash from operating activities 682,516 306,434

Cash flows from investing activities
Purchase of intangible fixed assets (18,959 ) (149,572 )
Purchase of tangible fixed assets (71,581 ) (15,490 )
Sale of intangible fixed assets 343 -
Sale of tangible fixed assets 985 500
Interest received 27,309 6,345
Net cash from investing activities (61,903 ) (158,217 )

Cash flows from financing activities
Group Loans 423,036 -
Capital repayments in year (7,980 ) -
Equity dividends paid (423,036 ) -
Net cash from financing activities (7,980 ) -

Increase in cash and cash equivalents 612,633 148,217
Cash and cash equivalents at beginning of
year

2

760,542

612,325

Cash and cash equivalents at end of year 2 1,373,175 760,542

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Cash Flow Statement
for the Year Ended 31 December 2023

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS
2023 2022
£ £
Profit before taxation 327,093 233,018
Depreciation charges 143,860 114,460
Loss/(profit) on disposal of fixed assets 1,839 (500 )
Finance costs 5,443 -
Finance income (27,309 ) (6,345 )
450,926 340,633
Decrease in stocks 188,439 22,192
Decrease/(increase) in trade and other debtors 59,554 (382,510 )
Increase in trade and other creditors 94,525 220,767
Cash generated from operations 793,444 201,082

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2023
31/12/23 1/1/23
£ £
Cash and cash equivalents 1,373,175 760,542
Year ended 31 December 2022
31/12/22 1/1/22
£ £
Cash and cash equivalents 760,542 612,325


3. ANALYSIS OF CHANGES IN NET FUNDS

Other
non-cash
At 1/1/23 Cash flow changes At 31/12/23
£ £ £ £
Net cash
Cash at bank
and in hand 760,542 612,633 1,373,175
760,542 612,633 1,373,175
Debt
Finance leases - 7,980 - (66,198 )
- 7,980 - (66,198 )
Total 760,542 620,613 - 1,306,977

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Top Dental (Products) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Improvements to property - in accordance with the property
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 15% on reducing balance
Computer equipment - Straight line over 3 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Financial assets are recognised in the company's statement of financial position when the company becomes
party to the contractual provisions of the instrument.
Basic financial assets, which include trade and other receivables, amounts owed from group undertakings and
cash and bank balances, are initially measured at fair value and are subsequently carried at amortised cost
using the effective interest method less any allowance for expected credit losses. Trade receivables are
generally due for settlement within 30 days.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
The company leases equipment. Rental contracts are typically made for fixed periods of 5 years but may have extension options.
Contracts may contain both lease and non-lease components. The company allocates the consideration in the contract to the lease and non-lease components based on their relative stand-alone prices.
Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions.
The lease agreements do not impose any covenants other than the security interests in the leased assets
that are held by the lessor. Leased assets may not be used as security for borrowing purposes.
Until the 2022 financial year, leases of plant and equipment were classified as either finance leases or operating leases.

From 1 January 2023, leases are recognised as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the company.
Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities
include the net present value of the following lease payments:
o Fixed payments (including in-substance fixed payments), less any lease incentives receivable;
o Variable lease payments that are based on an index or a rate, initially measured using the index or rate as
at the commencement date;
o Amounts expected to be payable by the company under residual value guarantees;
o The exercise price of a purchase option if the company is reasonably certain to exercise that option; and
o Payments of penalties for terminating the lease, if the lease term reflects the company exercising that
option.
Lease payments to be made under reasonably certain extension options are also included in the
measurement of the liability.
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily
determined, which is generally the case for leases in the company, the lessee's incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and conditions.
Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or
loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period.
Right-of-use assets are measured at cost comprising the following:
o The amount of the initial measurement of lease liability;
o Any lease payments made at or before the commencement date less any lease incentives received;
o Any initial direct costs; and
o Restoration costs.
Right-of-use assets are generally depreciated over the shorter of the asset's useful life and the lease term on a straight-line basis. If the company is reasonably certain to exercise a purchase option, the right-of-use
asset is depreciated over the underlying asset's useful life.


Lease accounting
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily
determined, which is generally the case for leases in the company, the lessee's incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and conditions.
o To determine the incremental borrowing rate, the company:
o Where possible, uses recent third-party financing received by the individual lessee as a starting point,
adjusted to reflect changes in financing conditions since third party financing was received;
o Uses a build-up approach that starts with a risk-free interest rate adjusted for credit risk for leases held by
the company, which does not have recent third party financing; and
o Makes adjustments specific to the lease, e.g. term, currency and security.

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

2. ACCOUNTING POLICIES - continued
The company used an average borrowing rates of 1.7% across all leases.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. TURNOVER

The turnover and profit before taxation are attributable to the principal activities of the company.

An analysis of turnover by class of business is given below:

2023 2022
£ £
Dental Wholesale 4,987,202 4,666,525
Dental Retail 197,000 268,753
5,184,202 4,935,278

An analysis of turnover by geographical market is given below:

2023 2022
£ £
United Kingdom 3,962,202 3,750,654
Europe 953,000 606,000
Rest of the world 269,000 578,624
5,184,202 4,935,278

4. EMPLOYEES AND DIRECTORS
2023 2022
£ £
Wages and salaries 693,099 630,705
Social security costs 65,086 54,868
Other pension costs 14,977 13,594
773,162 699,167

The average number of employees during the year was as follows:
2023 2022

Sales 2 4
Administration 10 5
Research & Development 1 1
Production 12 13
25 23

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

4. EMPLOYEES AND DIRECTORS - continued

2023 2022
£ £
Directors' remuneration 37,470 -
Directors' pension contributions to money purchase schemes 770 -

5. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2023 2022
£ £
Hire of plant and machinery 12,171 14,735
Depreciation - owned assets 102,078 89,502
Depreciation - assets on finance leases 11,127 -
Loss/(profit) on disposal of fixed assets 1,839 (500 )
Patents and licences amortisation 30,680 24,958
Auditors' remuneration 4,500 8,750
Foreign exchange differences (2,425 ) -

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2023 2022
£ £
Finance Charges 5,443 -

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2023 2022
£ £
Current tax:
UK corporation tax 79,484 51,788

Deferred tax 1,387 3,349
Tax on profit 80,871 55,137

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

7. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2023 2022
£ £
Profit before tax 327,093 233,018
Profit multiplied by the standard rate of corporation tax in the UK of
23.520% (2022 - 19%)

76,932

44,273

Effects of:
Expenses not deductible for tax purposes 337 661
Depreciation in excess of capital allowances 5,199 6,867
Deferred Tax 1,387 3,349
Balancing adjustment - (13 )
Unrealised gain/finance lease (2,984 ) -
Total tax charge 80,871 55,137

8. DIVIDENDS
2023 2022
£ £
Interim 423,036 -

9. INTANGIBLE FIXED ASSETS
Patents and
licences
£
COST
At 1 January 2023 292,566
Additions 18,984
Disposals (343 )
At 31 December 2023 311,207
AMORTISATION
At 1 January 2023 46,357
Amortisation for year 30,680
At 31 December 2023 77,037
NET BOOK VALUE
At 31 December 2023 234,170
At 31 December 2022 246,209

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

10. TANGIBLE FIXED ASSETS
Fixtures
Improvements Plant and and Computer
to property machinery fittings equipment Totals
£ £ £ £ £
COST
At 1 January 2023 200,782 534,776 60,623 14,053 810,234
Additions 9,069 133,006 - 3,684 145,759
Disposals - (5,485 ) - - (5,485 )
At 31 December 2023 209,851 662,297 60,623 17,737 950,508
DEPRECIATION
At 1 January 2023 111,801 311,744 41,580 12,692 477,817
Charge for year 20,834 71,600 18,619 2,152 113,205
Eliminated on disposal - (2,661 ) - - (2,661 )
At 31 December 2023 132,635 380,683 60,199 14,844 588,361
NET BOOK VALUE
At 31 December 2023 77,216 281,614 424 2,893 362,147
At 31 December 2022 88,981 223,032 19,043 1,361 332,417

Fixed assets, included in the above, which are held under finance leases are as follows:
Plant and
machinery
£
COST
Additions 74,178
At 31 December 2023 74,178
DEPRECIATION
Charge for year 11,127
At 31 December 2023 11,127
NET BOOK VALUE
At 31 December 2023 63,051

11. STOCKS
2023 2022
£ £
Stocks 437,610 626,049

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£ £
Trade debtors 629,197 682,080
Other debtors 480 -
Prepayments 58,284 65,435
687,961 747,515

13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£ £
Finance leases (see note 15) 13,374 -
Trade creditors 396,133 365,752
Amounts owed to group undertakings 423,036 -
Tax 25,787 51,788
Social security and other taxes 19,262 18,188
VAT 94,757 18,167
Other creditors 3,728 45,595
Accrued expenses 107,628 79,281
1,083,705 578,771

14. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£ £
Finance leases (see note 15) 52,824 -

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

15. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Finance leases
2023 2022
£ £
Gross obligations repayable:
Within one year 19,908 -
Between one and five years 66,019 -
85,927 -

Finance charges repayable:
Within one year 6,534 -
Between one and five years 13,195 -
19,729 -

Net obligations repayable:
Within one year 13,374 -
Between one and five years 52,824 -
66,198 -

Non-cancellable
operating leases
2023 2022
£ £
Within one year 136,350 145,100
Between one and five years 34,088 187,350
170,438 332,450

16. PROVISIONS FOR LIABILITIES
2023 2022
£ £
Deferred tax
Accelerated capital allowances 27,973 26,586

Deferred tax
£
Balance at 1 January 2023 26,586
Provided during year 1,387
Balance at 31 December 2023 27,973

Top Dental (Products) Limited (Registered number: 04261332)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

17. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £ £
100 Ordinary £1 100 100

18. RESERVES
Retained
earnings
£

At 1 January 2023 2,107,275
Profit for the year 246,222
Dividends (423,036 )
At 31 December 2023 1,930,461

19. ULTIMATE PARENT COMPANY

The company's ultimate parent company is Carl Bennet AB, a company incorporated in Sweden.

The largest group of which the company is a member and for which consolidated group financial statements are prepared is Carl Bennet AB. The principle place of business is Box 10035, S-434 21 Kungsbacka, Sweden.

The smallest group of which the company is a member and for which consolidated group financial statements are prepared is Lifco AB, a company incorporated in Sweden. The principle place of business is Verkmöstraregatan 1, SE-745 85 Enköpitig, Sweden.

20. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Carl Bennet by virtue of his controlling shareholdings within Carl Bennet AB